Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.
Scope of the Report:
The global Neuroprotective Agents market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuroprotective Agents.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Neuroprotective Agents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuroprotective Agents market by product type and applications/end industries.
Market Segment by Companies, this report covers
Genervon Biopharmaceuticals
NeuroVive Pharmaceutical
Ceregene
Neuren Pharmaceuticals
Allon Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cerebrovascular Diseases
Neurodegenerative Disorders
Ophthalmic Diseases
Traumatic CNS Injuries
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
Table of Contents
1 Neuroprotective Agents Market Overview
1.1 Product Overview and Scope of Neuroprotective Agents
1.2 Classification of Neuroprotective Agents by Types
1.2.1 Global Neuroprotective Agents Revenue Comparison by Types (2019-2024)
1.2.2 Global Neuroprotective Agents Revenue Market Share by Types in 2018
1.2.3 Cerebrovascular Diseases
1.2.4 Neurodegenerative Disorders
1.2.5 Ophthalmic Diseases
1.2.6 Traumatic CNS Injuries
1.3 Global Neuroprotective Agents Market by Application
1.3.1 Global Neuroprotective Agents Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neuroprotective Agents Market by Regions
1.4.1 Global Neuroprotective Agents Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Neuroprotective Agents Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroprotective Agents Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroprotective Agents Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Neuroprotective Agents Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroprotective Agents Status and Prospect (2014-2024)
1.5 Global Market Size of Neuroprotective Agents (2014-2024)
2 Manufacturers Profiles
2.1 Genervon Biopharmaceuticals
2.1.1 Business Overview
2.1.2 Neuroprotective Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genervon Biopharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
2.2 NeuroVive Pharmaceutical
2.2.1 Business Overview
2.2.2 Neuroprotective Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 NeuroVive Pharmaceutical Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
2.3 Ceregene
2.3.1 Business Overview
2.3.2 Neuroprotective Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ceregene Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
2.4 Neuren Pharmaceuticals
2.4.1 Business Overview
2.4.2 Neuroprotective Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Neuren Pharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
2.5 Allon Therapeutics
2.5.1 Business Overview
2.5.2 Neuroprotective Agents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Allon Therapeutics Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuroprotective Agents Market Competition, by Players
3.1 Global Neuroprotective Agents Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroprotective Agents Players Market Share
3.2.2 Top 10 Neuroprotective Agents Players Market Share
3.3 Market Competition Trend
4 Global Neuroprotective Agents Market Size by Regions
4.1 Global Neuroprotective Agents Revenue and Market Share by Regions
4.2 North America Neuroprotective Agents Revenue and Growth Rate (2014-2019)
4.3 Europe Neuroprotective Agents Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Neuroprotective Agents Revenue and Growth Rate (2014-2019)
4.5 South America Neuroprotective Agents Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Neuroprotective Agents Revenue and Growth Rate (2014-2019)
5 North America Neuroprotective Agents Revenue by Countries
5.1 North America Neuroprotective Agents Revenue by Countries (2014-2019)
5.2 USA Neuroprotective Agents Revenue and Growth Rate (2014-2019)
5.3 Canada Neuroprotective Agents Revenue and Growth Rate (2014-2019)
5.4 Mexico Neuroprotective Agents Revenue and Growth Rate (2014-2019)
6 Europe Neuroprotective Agents Revenue by Countries
6.1 Europe Neuroprotective Agents Revenue by Countries (2014-2019)
6.2 Germany Neuroprotective Agents Revenue and Growth Rate (2014-2019)
6.3 UK Neuroprotective Agents Revenue and Growth Rate (2014-2019)
6.4 France Neuroprotective Agents Revenue and Growth Rate (2014-2019)
6.5 Russia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
6.6 Italy Neuroprotective Agents Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Neuroprotective Agents Revenue by Countries
7.1 Asia-Pacific Neuroprotective Agents Revenue by Countries (2014-2019)
7.2 China Neuroprotective Agents Revenue and Growth Rate (2014-2019)
7.3 Japan Neuroprotective Agents Revenue and Growth Rate (2014-2019)
7.4 Korea Neuroprotective Agents Revenue and Growth Rate (2014-2019)
7.5 India Neuroprotective Agents Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
8 South America Neuroprotective Agents Revenue by Countries
8.1 South America Neuroprotective Agents Revenue by Countries (2014-2019)
8.2 Brazil Neuroprotective Agents Revenue and Growth Rate (2014-2019)
8.3 Argentina Neuroprotective Agents Revenue and Growth Rate (2014-2019)
8.4 Colombia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Neuroprotective Agents by Countries
9.1 Middle East and Africa Neuroprotective Agents Revenue by Countries (2014-2019)
9.2 Saudi Arabia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
9.3 UAE Neuroprotective Agents Revenue and Growth Rate (2014-2019)
9.4 Egypt Neuroprotective Agents Revenue and Growth Rate (2014-2019)
9.5 Nigeria Neuroprotective Agents Revenue and Growth Rate (2014-2019)
9.6 South Africa Neuroprotective Agents Revenue and Growth Rate (2014-2019)
10 Global Neuroprotective Agents Market Segment by Type
10.1 Global Neuroprotective Agents Revenue and Market Share by Type (2014-2019)
10.2 Global Neuroprotective Agents Market Forecast by Type (2019-2024)
10.3 Cerebrovascular Diseases Revenue Growth Rate (2014-2024)
10.4 Neurodegenerative Disorders Revenue Growth Rate (2014-2024)
10.5 Ophthalmic Diseases Revenue Growth Rate (2014-2024)
10.6 Traumatic CNS Injuries Revenue Growth Rate (2014-2024)
11 Global Neuroprotective Agents Market Segment by Application
11.1 Global Neuroprotective Agents Revenue Market Share by Application (2014-2019)
11.2 Neuroprotective Agents Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Neuroprotective Agents Market Size Forecast (2019-2024)
12.1 Global Neuroprotective Agents Market Size Forecast (2019-2024)
12.2 Global Neuroprotective Agents Market Forecast by Regions (2019-2024)
12.3 North America Neuroprotective Agents Revenue Market Forecast (2019-2024)
12.4 Europe Neuroprotective Agents Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Neuroprotective Agents Revenue Market Forecast (2019-2024)
12.6 South America Neuroprotective Agents Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Neuroprotective Agents Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Neuroprotective Agents Picture
Table Product Specifications of Neuroprotective Agents
Table Global Neuroprotective Agents and Revenue (Million USD) Market Split by Product Type
Figure Global Neuroprotective Agents Revenue Market Share by Types in 2018
Figure Cerebrovascular Diseases Picture
Figure Neurodegenerative Disorders Picture
Figure Ophthalmic Diseases Picture
Figure Traumatic CNS Injuries Picture
Table Global Neuroprotective Agents Revenue (Million USD) by Application (2014-2024)
Figure Neuroprotective Agents Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Neuroprotective Agents Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Neuroprotective Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Neuroprotective Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Neuroprotective Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Neuroprotective Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Neuroprotective Agents Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Neuroprotective Agents Revenue (Million USD) and Growth Rate (2014-2024)
Table Genervon Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Genervon Biopharmaceuticals Neuroprotective Agents Type and Applications
Table Genervon Biopharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
Table NeuroVive Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table NeuroVive Pharmaceutical Neuroprotective Agents Type and Applications
Table NeuroVive Pharmaceutical Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Ceregene Basic Information, Manufacturing Base and Competitors
Table Ceregene Neuroprotective Agents Type and Applications
Table Ceregene Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Neuren Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Neuren Pharmaceuticals Neuroprotective Agents Type and Applications
Table Neuren Pharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Allon Therapeutics Basic Information, Manufacturing Base and Competitors
Table Allon Therapeutics Neuroprotective Agents Type and Applications
Table Allon Therapeutics Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2018)
Table Global Neuroprotective Agents Revenue (Million USD) by Players (2014-2019)
Table Global Neuroprotective Agents Revenue Share by Players (2014-2019)
Figure Global Neuroprotective Agents Revenue Share by Players in 2017
Figure Global Neuroprotective Agents Revenue Share by Players in 2018
Figure Global Top 5 Players Neuroprotective Agents Revenue Market Share in 2018
Figure Global Top 10 Players Neuroprotective Agents Revenue Market Share in 2018
Figure Global Neuroprotective Agents Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Neuroprotective Agents Revenue (Million USD) by Regions (2014-2019)
Table Global Neuroprotective Agents Revenue Market Share by Regions (2014-2019)
Figure Global Neuroprotective Agents Revenue Market Share by Regions (2014-2019)
Figure Global Neuroprotective Agents Revenue Market Share by Regions in 2018
Figure North America Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Europe Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure South America Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Table North America Neuroprotective Agents Revenue by Countries (2014-2019)
Table North America Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure North America Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure North America Neuroprotective Agents Revenue Market Share by Countries in 2018
Figure USA Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Canada Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Mexico Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Table Europe Neuroprotective Agents Revenue (Million USD) by Countries (2014-2019)
Figure Europe Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure Europe Neuroprotective Agents Revenue Market Share by Countries in 2018
Figure Germany Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure UK Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure France Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Russia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Italy Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Neuroprotective Agents Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Neuroprotective Agents Revenue Market Share by Countries in 2018
Figure China Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Japan Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Korea Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure India Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Table South America Neuroprotective Agents Revenue by Countries (2014-2019)
Table South America Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure South America Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure South America Neuroprotective Agents Revenue Market Share by Countries in 2018
Figure Brazil Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Argentina Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Colombia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Neuroprotective Agents Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroprotective Agents Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroprotective Agents Revenue Market Share by Countries in 2018
Figure Saudi Arabia Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure UAE Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Egypt Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure Nigeria Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Figure South Africa Neuroprotective Agents Revenue and Growth Rate (2014-2019)
Table Global Neuroprotective Agents Revenue (Million USD) by Type (2014-2019)
Table Global Neuroprotective Agents Revenue Share by Type (2014-2019)
Figure Global Neuroprotective Agents Revenue Share by Type (2014-2019)
Figure Global Neuroprotective Agents Revenue Share by Type in 2019
Table Global Neuroprotective Agents Revenue Forecast by Type (2019-2024)
Figure Global Neuroprotective Agents Market Share Forecast by Type (2019-2024)
Figure Global Cerebrovascular Diseases Revenue Growth Rate (2014-2019)
Figure Global Neurodegenerative Disorders Revenue Growth Rate (2014-2019)
Figure Global Ophthalmic Diseases Revenue Growth Rate (2014-2019)
Figure Global Traumatic CNS Injuries Revenue Growth Rate (2014-2019)
Table Global Neuroprotective Agents Revenue by Application (2014-2019)
Table Global Neuroprotective Agents Revenue Share by Application (2014-2019)
Figure Global Neuroprotective Agents Revenue Share by Application (2014-2019)
Figure Global Neuroprotective Agents Revenue Share by Application in 2019
Table Global Neuroprotective Agents Revenue Forecast by Application (2019-2024)
Figure Global Neuroprotective Agents Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Neuroprotective Agents Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Neuroprotective Agents Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Neuroprotective Agents Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Neuroprotective Agents Revenue Market Forecast (2019-2024)
Figure Europe Neuroprotective Agents Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Neuroprotective Agents Revenue Market Forecast (2019-2024)
Figure South America Neuroprotective Agents Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Neuroprotective Agents Revenue Market Forecast (2019-2024)
Overview of the Global DNA Damaging Agents Market:
The report discusses everything a marketer requires before investing in the global DNA Damaging Agents Market during the forecast period 2023-2030. It provides deta...
Overview of the Global Digital Securities Transfer Agents Market:
The report discusses everything a marketer requires before investing in the global Digital Securities Transfer Agents Market during the forecast peri...
Overview of the Global Flavor Masking Agents for Food and Beverages Market:
The report discusses everything a marketer requires before investing in the global Flavor Masking Agents for Food and Beverages Market duri...
Overview of the Global Healthcare Conversational Agents Market:
The report discusses everything a marketer requires before investing in the global Healthcare Conversational Agents Market during the forecast period 2...
Overview of the Global Health Virtual Agents Market:
The report discusses everything a marketer requires before investing in the global Health Virtual Agents Market during the forecast period 2023-2030. It provides ...
The global Oilfield Foaming Agents Products market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...
The global Oilfield Foaming Agents market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...
The global Food Bulking Agents market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
Overview of the Global Medical Imaging Contrast Agents Injector Market:
The report discusses everything a marketer requires before investing in the global Medical Imaging Contrast Agents Injector Market during the f...
The global Oral hypoglycemic agents and insulin analogues market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will h...